CD4 and stroke disorder: To test whether microglial phenotypes can be specifically skewed by the CD4+ T cell subsets of functionally opposing THELPER cell subpopulations, we differentiated TH1 and TREG in vitro (Figure 3—figure supplement 1A) and tested whether these THELPER cells can reprogram the stroke-associated microglia.